These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 17845211)

  • 1. Agonists of proteinase-activated receptor-2 affect transendothelial migration and apoptosis of human neutrophils.
    Shpacovitch VM; Seeliger S; Huber-Lang M; Balkow S; Feld M; Hollenberg MD; Sarma VJ; Ward PA; Strey A; Gerke V; Sommerhoff CP; Vergnolle N; Steinhoff M
    Exp Dermatol; 2007 Oct; 16(10):799-806. PubMed ID: 17845211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of lactoferrin and IL-8 release from human neutrophils by tryptic enzymes via proteinase activated receptor-2.
    Wang H; He S
    Cell Biol Int; 2006 Sep; 30(9):688-97. PubMed ID: 16820307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Agonists of proteinase-activated receptor-2 modulate human neutrophil cytokine secretion, expression of cell adhesion molecules, and migration within 3-D collagen lattices.
    Shpacovitch VM; Varga G; Strey A; Gunzer M; Mooren F; Buddenkotte J; Vergnolle N; Sommerhoff CP; Grabbe S; Gerke V; Homey B; Hollenberg M; Luger TA; Steinhoff M
    J Leukoc Biol; 2004 Aug; 76(2):388-98. PubMed ID: 15155775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of tissue factor and tissue factor pathway inhibitor-1 by neutrophil proteases.
    Steppich BA; Seitz I; Busch G; Stein A; Ott I
    Thromb Haemost; 2008 Dec; 100(6):1068-75. PubMed ID: 19132232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The antidiabetic agent, gliclazide, reduces high insulin-enhanced neutrophil-transendothelial migration through direct effects on the endothelium.
    Okouchi M; Okayama N; Omi H; Imaeda K; Fukutomi T; Nakamura A; Itoh M
    Diabetes Metab Res Rev; 2004; 20(3):232-8. PubMed ID: 15133755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of serine proteases on the migration of normal and tumor cells: implications for tumor microenvironment.
    Elzer KL; Heitzman DA; Chernin MI; Novak JF
    Integr Cancer Ther; 2008 Dec; 7(4):282-94. PubMed ID: 19116224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ANCA induces beta2 integrin and CXC chemokine-dependent neutrophil-endothelial cell interactions that mimic those of highly cytokine-activated endothelium.
    Calderwood JW; Williams JM; Morgan MD; Nash GB; Savage CO
    J Leukoc Biol; 2005 Jan; 77(1):33-43. PubMed ID: 15459232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of neutrophils in severe sepsis.
    Alves-Filho JC; de Freitas A; Spiller F; Souto FO; Cunha FQ
    Shock; 2008 Oct; 30 Suppl 1():3-9. PubMed ID: 18704017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective role for protease-activated receptor-2 against influenza virus pathogenesis via an IFN-gamma-dependent pathway.
    Khoufache K; LeBouder F; Morello E; Laurent F; Riffault S; Andrade-Gordon P; Boullier S; Rousset P; Vergnolle N; Riteau B
    J Immunol; 2009 Jun; 182(12):7795-802. PubMed ID: 19494303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of monocyte chemoattractant protein-1 release from A549 cells by agonists of protease-activated receptor-1 and -2.
    Wang H; Yi T; Zheng Y; He S
    Eur J Cell Biol; 2007 Apr; 86(4):233-42. PubMed ID: 17280738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of protease-activated receptors PAR-1 and PAR-2 in the repair of 16HBE 14o(-) epithelial cell monolayers in vitro.
    Ewen D; Clarke SL; Smith JR; Berger C; Salmon G; Trevethick M; Shute JK
    Clin Exp Allergy; 2010 Mar; 40(3):435-49. PubMed ID: 20210813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammatory interaction between LIGHT and proteinase-activated receptor-2 in endothelial cells: potential role in atherogenesis.
    Sandberg WJ; Halvorsen B; Yndestad A; Smith C; Otterdal K; Brosstad FR; Frøland SS; Olofsson PS; Damås JK; Gullestad L; Hansson GK; Oie E; Aukrust P
    Circ Res; 2009 Jan; 104(1):60-8. PubMed ID: 19023130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutrophils from MMP-9- or neutrophil elastase-deficient mice show no defect in transendothelial migration under flow in vitro.
    Allport JR; Lim YC; Shipley JM; Senior RM; Shapiro SD; Matsuyoshi N; Vestweber D; Luscinskas FW
    J Leukoc Biol; 2002 May; 71(5):821-8. PubMed ID: 11994507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of anticoagulants and the role of thrombin on neutrophil-endothelial cell interactions in septic shock.
    Tsen A; Kirschenbaum LA; LaRow C; Khan R; Kurtz S; Bansal S; Astiz ME
    Shock; 2009 Feb; 31(2):120-4. PubMed ID: 18636042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of recombinant activated protein C and low-dose heparin on neutrophil-endothelial cell interactions in septic shock.
    Kirschenbaum LA; Lopez WC; Ohrum P; Tsen A; Khazin J; Astiz ME
    Crit Care Med; 2006 Aug; 34(8):2207-12. PubMed ID: 16775572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteinase-activated receptor-2 in the skin: receptor expression, activation and function during health and disease.
    Rattenholl A; Steinhoff M
    Drug News Perspect; 2008 Sep; 21(7):369-81. PubMed ID: 19259550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepta and octapeptide agonists of protease-activated receptor 2.
    Devlin MG; Pfeiffer B; Flanagan B; Beyer RL; Cocks TM; Fairlie DP
    J Pept Sci; 2007 Dec; 13(12):856-61. PubMed ID: 17890655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of protease-activated receptor-1 in endothelial nitric oxide synthase-Thr495 phosphorylation.
    Watts VL; Motley ED
    Exp Biol Med (Maywood); 2009 Feb; 234(2):132-9. PubMed ID: 19064940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of inflammatory cytokine release from human umbilical vein endothelial cells by agonists of proteinase-activated receptor-2.
    Niu QX; Chen HQ; Chen ZY; Fu YL; Lin JL; He SH
    Clin Exp Pharmacol Physiol; 2008 Jan; 35(1):89-96. PubMed ID: 18047634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrathecal administration of proteinase-activated receptor-2 agonists produces hyperalgesia by exciting the cell bodies of primary sensory neurons.
    Alier KA; Endicott JA; Stemkowski PL; Cenac N; Cellars L; Chapman K; Andrade-Gordon P; Vergnolle N; Smith PA
    J Pharmacol Exp Ther; 2008 Jan; 324(1):224-33. PubMed ID: 17921188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.